Market revenue in 2023 | USD 114.6 millions |
Market revenue in 2030 | USD 146.0 millions |
Growth rate | 3.5% (CAGR from 2023 to 2030) |
Largest segment | Treatment |
Fastest growing segment | Treatment |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD millions |
Market segmentation | Diagnosis, Treatment |
Key market players worldwide | Mars Group Holdings Corp, Nestle Purina Petcare, Colgate-Palmolive Co, JM Smucker Co, General Mills Inc, Zoetis Inc Class A, Merck & Co Inc, Elanco Animal Health Inc, Phibro Animal Health Corp Class A, Ceva Santé Animale, Boehringer Ingelheim, Dechra Pharmaceuticals, Insud Pharma, Vedco, Mission Pharmacal, Neogen Corp, JP Pharma, IDEXX Laboratories Inc, FUJIFILM Holdings Corp, Carestream, Mindray Medical International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary renal disease market will help companies and investors design strategic landscapes.
Treatment was the largest segment with a revenue share of 68.41% in 2023. Horizon Databook has segmented the Saudi Arabia veterinary renal disease market based on diagnosis, treatment covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia veterinary renal disease market, including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia veterinary renal disease market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account